California State Teachers Retirement System (CalSTRS)
RARE icon

California State Teachers Retirement System (CalSTRS)’s Ultragenyx Pharmaceutical RARE Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39M Sell
101,471
-3,179
-3% -$79K ﹤0.01% 1318
2026
Q1 		$2.19M Buy
104,650
+21,313
+26% +$480K ﹤0.01% 1468
2025
Q4 		$1.92M Buy
83,337
+2,447
+3% +$80.5K ﹤0.01% 1438
2025
Q3 		$2.43M Buy
80,890
+3,731
+5% +$112K ﹤0.01% 1302
2025
Q2 		$2.81M Buy
77,159
+161
+0.2% +$5.8K ﹤0.01% 1186
2025
Q1 		$2.79M Sell
76,998
-1,053
-1% -$43.8K ﹤0.01% 1166
2024
Q4 		$3.28M Buy
78,051
+268
+0.3% +$13.3K ﹤0.01% 1107
2024
Q3 		$4.32M Buy
77,783
+4,342
+6% +$221K 0.01% 988
2024
Q2 		$3.02M Sell
73,441
-972
-1% -$41.5K ﹤0.01% 1122
2024
Q1 		$3.47M Sell
74,413
-2,662
-3% -$126K ﹤0.01% 1086
2023
Q4 		$3.69M Sell
77,075
-603
-0.8% -$23.4K 0.01% 1074
2023
Q3 		$2.77M Sell
77,678
-6,807
-8% -$270K ﹤0.01% 1204
2023
Q2 		$3.9M Buy
84,485
+982
+1% +$45.5K 0.01% 1098
2023
Q1 		$3.35M Sell
83,503
-1,272
-2% -$54.6K 0.01% 1167
2022
Q4 		$3.93M Buy
84,775
+1,083
+1% +$42.6K 0.01% 1080
2022
Q3 		$3.47M Sell
83,692
-3,959
-5% -$203K 0.01% 1118
2022
Q2 		$5.23M Buy
87,651
+1,692
+2% +$104K 0.01% 930
2022
Q1 		$6.24M Sell
85,959
-6,927
-7% -$482K 0.01% 935
2021
Q4 		$7.81M Sell
92,886
-18,242
-16% -$1.48M 0.01% 885
2021
Q3 		$10M Sell
111,128
-6,223
-5% -$562K 0.01% 816
2021
Q2 		$11.2M Buy
117,351
+15,683
+15% +$1.63M 0.01% 786
2021
Q1 		$11.6M Buy
101,668
+1,181
+1% +$161K 0.02% 743
2020
Q4 		$13.9M Buy
100,487
+7,675
+8% +$910K 0.02% 643
2020
Q3 		$7.63M Buy
92,812
+7,292
+9% +$604K 0.01% 790
2020
Q2 		$6.69M Buy
85,520
+2,465
+3% +$163K 0.01% 809
2020
Q1 		$3.69M Sell
83,055
-411
-0.5% -$21.3K 0.01% 973
2019
Q4 		$3.56M Sell
83,466
-1,687
-2% -$69.6K 0.01% 1218
2019
Q3 		$3.64M Buy
85,153
+1,018
+1% +$55.3K 0.01% 1170
2019
Q2 		$5.34M Buy
84,135
+3,641
+5% +$232K 0.01% 957
2019
Q1 		$5.58M Buy
80,494
+5,711
+8% +$326K 0.01% 909
2018
Q4 		$3.25M Buy
74,783
+2,851
+4% +$156K 0.01% 1158
2018
Q3 		$5.49M Sell
71,932
-24
-0% -$1.95K 0.01% 975
2018
Q2 		$5.53M Buy
71,956
+4,095
+6% +$264K 0.01% 948
2018
Q1 		$3.46M Buy
67,861
+5,465
+9% +$275K 0.01% 1176
2017
Q4 		$2.89M Sell
62,396
-948
-1% -$46.5K 0.01% 1336
2017
Q3 		$3.37M Sell
63,344
-6,762
-10% -$401K 0.01% 1239
2017
Q2 		$4.35M Sell
70,106
-5,739
-8% -$346K 0.01% 1114
2017
Q1 		$5.14M Buy
75,845
+1,600
+2% +$122K 0.01% 1040
2016
Q4 		$5.22M Sell
74,245
-2,000
-3% -$142K 0.01% 1056
2016
Q3 		$5.41M Buy
76,245
+700
+0.9% +$44.7K 0.01% 1008
2016
Q2 		$3.69M Sell
75,545
-6,126
-8% -$396K 0.01% 1207
2016
Q1 		$5.17M Buy
81,671
+10,499
+15% +$687K 0.01% 1001
2015
Q4 		$7.98M Buy
71,172
+1,100
+2% +$110K 0.02% 713
2015
Q3 		$6.75M Buy
70,072
+4,500
+7% +$515K 0.02% 790
2015
Q2 		$6.71M Buy
65,572
+51,447
+364% +$3.99M 0.02% 856
2015
Q1 		$877K Buy
14,125
+1,100
+8% +$61.1K ﹤0.01% 2106
2014
Q4 		$572K Buy
13,025
+55
+0.4% +$2.52K ﹤0.01% 2396
2014
Q3 		$734K Buy
12,970
+870
+7% +$43.8K ﹤0.01% 2210
2014
Q2 		$543K Buy
12,100
+100
+0.8% +$4.12K ﹤0.01% 2449
2014
Q1 		$587K Buy
+12,000
New +$618K ﹤0.01% 2326

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s RARE Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Ultragenyx Pharmaceutical (RARE) stake by 3% in Q2 2026, selling an estimated $79K and leaving 101,471 shares worth $3.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1318.

California State Teachers Retirement System (CalSTRS) first reported a position in RARE in Q1 2014 and has held it in 50 quarters since. The position peaked at $13.9M in Q4 2020. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 101,471 shares of Ultragenyx Pharmaceutical worth $3.39M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 3,179 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $79K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1318 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 50 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Ultragenyx Pharmaceutical position peaked at $13.9M in Q4 2020.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.